The Clinical Coding and Schedule Development (CCSD) develops and maintains procedural and diagnostics nomenclature for private payers in England. Once codes are added to the Schedule, a rivate insurance company can develop reimbursement tariff for these procedures and tests.
The CCSD Group has approved the following diagnostic codes for publication to the CCSD Schedule in July/August with a recommended adoption date of 1st November 2018:
- 18S rRNA gene and Sequencing (3545G)
- ELA2 Cyclic Neutropenia Genetic Screen (3546G)
See full details here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.